We also revealed that lysyl oxidase–like protein 2 (LOXL2), a well-known regulator of tumor, is an endogenous ligand binding to the PEAR1-EMI domain and facilitating PEAR1 Ser891 phosphorylation, which is essential for the binding of PEAR1 to CD44. Here, PEAR1 is linked to neoplasm.